Michigan Officials Question High THC Weed Lab Results



Questions occur just after Michigan regulators filed formal problems towards just one of the state’s major cannabis screening laboratories final month. Hashish that assessments more than 28% THC, and at periods more than 40%, is topic for an automatic audit, and regulators say the lab success aren’t adding up.

Formal issues had been submitted by the Michigan Cannabis Regulatory Agency (CRA) in May possibly versus Viridis Laboratories, one particular of the leading lab screening businesses in the state, but the lab is in turn firing again with its individual countersuit. The CRA noted discrepancies in Viridis Laboratories lab success due to the fact December 2020, according to formal issues the CRA submitted on May possibly 19.

Generally customers problem the THC content material discovered in lab results, nevertheless THC level alone is not a dependable indicator of potency in all circumstances. Conversely, there is massive stress to drive up THC ranges across the board as it is one of the largest drivers of hashish gross sales.

“Potency inflation is an ongoing, longstanding, greatly known concern across hashish in the U.S. suitable now in lawful marketplaces … ” Lev Spivak-Birndorf, founder and main science officer for Ann Arbor-based mostly PSI Labs, told MLive. “I phone it the cycle of potency inflation: men and women want substantial efficiency, so then shops are underneath tension to try out and provide that … and that drives growers to search for labs that give the maximum final results, and hence, we have this rampant lab browsing that we have heading on.”

For each CRA policy, agents will audit results for any flower that assessments around 28% THC. And according to the grievances, Viridis samples hit this selection 8.9% of the time, which is reportedly greater than most labs across the condition.

Viridis was also subject matter to the major cannabis remember in the state’s history. Per Viridis’s court docket filings, an estimated 64,000 kilos of cannabis valued at nearly $230 million on Nov. 17, 2021, based on courtroom filings.

But Viridis submitted its individual formal complaint against the CRA in the state’s administrative courtroom, when litigation is ongoing. The Michigan Chamber of Commerce backed up Viridis by filing an amicus transient in aid of Viridis that reported the CRA recall “unconstitutionally exceeds the scope of the agency’s legislatively authorised mandate.”

Viridis officials say the statements are “meritless” and that they’re specific due to the fact the CRA would like a much more even participating in area with the confined quantity of screening laboratories.

“These CRA allegations towards Viridis are from very last August and carry on to be baseless, meritless and absolutely detached from science, specifics and details,” Viridis CEO Greg Michaud said.

“We intend to protect our business versus these false promises throughout the court procedure and clearly show the vindictive and retaliatory mother nature of the CRA’s actions which are plainly developed to trigger optimum disruption and hurt.

“Court-purchased proficiency check success that Viridis is in possession of, which the CRA experienced been withholding, will right contradict these results, and we’re confident the truth will prevail when all facts arrive to gentle. We hope these authorized proceedings will pave the way for more transparency, accountability, and reforms at the CRA. Our hope is that the CRA can just one day fulfill its legitimate mission of promoting individual and products security as a substitute of unfairly concentrating on Michigan firms trying to improve, contend and generate employment.”

MLive pointed out 1 occasion when a purported 40% THC sample was challenged. A dispensary was displaying flower with above 50% full cannabinoids and 40.3% THC. The Spott, a certified safety compliance lab in Kalamazoo, ran its very own test and reached a really various end result. In accordance to the Spott, the flower contained about 26.4% THC, compared to the 40.3% that the label claims.

Both of those cases of litigation are ongoing.